Table 3.
Univariate | Multivariate | OR | 95% CI | |
---|---|---|---|---|
Age, years | 0.44 | |||
Sex, female | 0.39 | |||
BMI | 0.67 | |||
Non-paroxysmal AF | 0.21 | 0.53 | 0.57 | 0.07–3.03 |
First session | 0.53 | |||
Congestive heart failure | 0.91 | |||
Hypertension | 0.33 | |||
Diabetes | 0.26 | 0.19 | 3.6 | 0.47–20.23 |
Stroke | 0.65 | |||
CHADS2 score | 0.69 | |||
LAV | 0.028 | 0.06 | 0.95 | 0.91–1.00 |
LVEF | 0.9 | |||
Focal ablation | 0.55 | |||
SVCI | 0.29 | 0.47 | 1.77 | 0.35–8.57 |
Substrate modifications | 0.37 | |||
MSDH | 0.0047 | 0.0073 | 1.13 | 1.04–1.25 |
AF, atrial fibrillation; BMI, body mass index; CA, catheter ablation; CI, confidence interval; LAV, left atrial volume; LVEF, left ventricular ejection fraction; MSDH, maximum shifting distance of the heart; OR, odds ratio; SVCI, superior vena cava isolation.